ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

91

AMERICAN LUNG ASSOCIATION MID-DAY SESSION

NATIONAL HEART, LUNG, BLOOD INSTITUTE, NIH MID-DAY SESSION MD3 COPDGENE: UPDATES IN COPD EPIDEMIOLOGY, IMAGING, AND BIOMARKERS 12:00 p.m. - 1:00 p.m. Marriott Marquis San Diego Marina Grand Ballroom 8-9 (Lobby Level, North Tower) Target Audience Researchers, medical trainees, those with an interest in COPD pathogenesis Objectives At the conclusion of this session, the participant will be able to: • learn about how COPD is affected by social determinants of health Genetic Epidemiology of COPD (COPDgene) is an NHLBI-funded multi-site longitudinal cohort study of current and former smokers to better understand risk factors, natural history, and genetic contributions of COPD as well as other smoking-related diseases. COPDGene uses extensive longitudinal imaging, physiology, and Omics molecular data in combination w/genetics in the COPDGene cohort to identify high-risk subgroups with distinct diagnostic, prognostic, and therapeutic implications. Funded for 15 years, COPDGene originally enrolled 10,000 participants w/significant smoking history. COPDGene study investigators will describe progress and recent findings ranging from how social determinants of health impact COPD to identifying COPD subtypes using omics data. 12:00 COPDGene Progress and Clinical Translation 12:12 Social Determinants of Health and COPD 12:24 Advances in COPD Imaging 12:36 Innovation, Advances and Opportunities in COPD Epigenetics 12:48 COPD Subtyping with Omics • learn about imaging in the COPDGene study • learn about COPD epigenetics and other omics

MD2 STUDY UPDATES FROM THE

AMERICAN LUNG ASSOCIATION’S AIRWAY CLINICAL RESEARCH CENTERS NETWORK Marriott Marquis San Diego Marina Pacific Ballroom 24-26 (Ground Floor, North Tower) Target Audience Physicians, clinical scientists, nurses, paraprofessionals, educators, health care providers Objectives At the conclusion of this session, the participant will be able to: • apply bronchodilator responsiveness to treatment of patients with uncontrolled asthma • better diagnose early onset and precursors of chronic lower respiratory disease in young adults. • apply social network strategies for identification and enrollment of participants for clinical research studies The purpose of the session is to discuss ongoing research initiatives within the American Lung Association Airways Clinical Research Centers network. 12:00 Introduction 12:05 Social Media Recruitment Strategies in an Online Asthma Trial 12:15 Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Care Outcomes in Adolescents and Young Adults (MATCH) 12:00 p.m. - 1:00 p.m.

12:25 LEEP / COVID Part 2 12:35 Bronchodilator response in asthma 12:45 Questions

ATS 2024 Conference Program • San Diego, CA